Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response
Background After sustained virological response (SVR), liver stiffness (LS) usually decreases. However, information related to the impact of HIV co-infection in patients with advanced fibrosis is scarce. The aim was to analyze the impact of HIV co-infection on the LS dynamics after HCV cure. Methods...
| Autores: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | INCLIVA |
| Repositorio: | r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA |
| OAI Identifier: | oai:incliva.fundanetsuite.com:p20652 |
| Acceso en línea: | https://incliva.portalinvestigacion.com/publicaciones/20652 |
| Access Level: | acceso abierto |
| Palabra clave: | Liver stiffness HIV Hepatitis C Sustained viral response Transient elastography |
| id |
ES_bf1ca4be3fad642a347de2edbb499785 |
|---|---|
| oai_identifier_str |
oai:incliva.fundanetsuite.com:p20652 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological responseMartín-Carmona, JCorma-Gómez, AMoyano, JMTéllez, FArenga-Barrios, DSerrano-Fuentes, MVázquez, ACMCorona-Mata, DLorite, MNNVera-Méndez, FJBarroso, IPalacios, Rde los Santos, IBelinchón, OGalera, CImaz, AMerino, DReus-Bañuls, SJGalindo, MJLópez-Zuñiga, MAPineda, JAMacías, JLiver stiffnessHIVHepatitis CSustained viral responseTransient elastographyBackground After sustained virological response (SVR), liver stiffness (LS) usually decreases. However, information related to the impact of HIV co-infection in patients with advanced fibrosis is scarce. The aim was to analyze the impact of HIV co-infection on the LS dynamics after HCV cure. Methods Prospective study conducted in the GEHEP-011 multicenter cohort (initiated in October 2011-November 2023, ID NCT04460157), including patients with chronic HCV infection, with or without HIV co-infection, fulfilling: 1) SVR with direct-acting antivirals; 2) pre-treatment LS >= 9.5 kPa; 3) available measurement of LS at SVR. Pre-treatment, SVR and annual post-treatment LS were assessed. The primary outcome was time to LS normalization achievement (<= 7.2 kPa) in two consecutive examinations. Findings 1138 patients were included, 678 (60%) of whom were living with HIV (PLWH). The median time between the first to the last measure was 35 (17-69) months. In total, 390 [34% (95% confidence interval, 31%-37%)] patients achieved LS normalization, 169 [37% (CI 95%, 34%-43%)] individuals with HCV mono-infection vs. 221 [32% (CI 95%, 29%-36%)] PLWH achieved LS normalization (p = 0.003). The propensity score (PS) for HIV infection was calculated. In a multivariate model for competing risks (death was the competing event) adjusted for HIV, PS and diabetes, HIV infection was associated with a lower probability of achieving normalization [sHR = 0.82 (95% CI, 0.67-1.00), p = 0.045]. Matching by closer PS was performed. In the resultant subset, the probability of achieving LS normalization was again lower in PLWH [sHR = 0.76 (0.56-0.97), p < 0.001]. Interpretation After SVR, the probability of reaching LS normalization is significantly lower in PLWH. This could have implications on the development of long-term clinical events. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).ELSEVIER2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://incliva.portalinvestigacion.com/publicaciones/20652EClinicalMedicineISSN: 25895370reponame:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVAinstname:INCLIVAInglésinfo:eu-repo/semantics/openAccessoai:incliva.fundanetsuite.com:p206522026-06-07T16:35:31Z |
| dc.title.none.fl_str_mv |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response |
| title |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response |
| spellingShingle |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response Martín-Carmona, J Liver stiffness HIV Hepatitis C Sustained viral response Transient elastography |
| title_short |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response |
| title_full |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response |
| title_fullStr |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response |
| title_full_unstemmed |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response |
| title_sort |
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response |
| dc.creator.none.fl_str_mv |
Martín-Carmona, J Corma-Gómez, A Moyano, JM Téllez, F Arenga-Barrios, D Serrano-Fuentes, M Vázquez, ACM Corona-Mata, D Lorite, MNN Vera-Méndez, FJ Barroso, I Palacios, R de los Santos, I Belinchón, O Galera, C Imaz, A Merino, D Reus-Bañuls, SJ Galindo, MJ López-Zuñiga, MA Pineda, JA Macías, J |
| author |
Martín-Carmona, J |
| author_facet |
Martín-Carmona, J Corma-Gómez, A Moyano, JM Téllez, F Arenga-Barrios, D Serrano-Fuentes, M Vázquez, ACM Corona-Mata, D Lorite, MNN Vera-Méndez, FJ Barroso, I Palacios, R de los Santos, I Belinchón, O Galera, C Imaz, A Merino, D Reus-Bañuls, SJ Galindo, MJ López-Zuñiga, MA Pineda, JA Macías, J |
| author_role |
author |
| author2 |
Corma-Gómez, A Moyano, JM Téllez, F Arenga-Barrios, D Serrano-Fuentes, M Vázquez, ACM Corona-Mata, D Lorite, MNN Vera-Méndez, FJ Barroso, I Palacios, R de los Santos, I Belinchón, O Galera, C Imaz, A Merino, D Reus-Bañuls, SJ Galindo, MJ López-Zuñiga, MA Pineda, JA Macías, J |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Liver stiffness HIV Hepatitis C Sustained viral response Transient elastography |
| topic |
Liver stiffness HIV Hepatitis C Sustained viral response Transient elastography |
| description |
Background After sustained virological response (SVR), liver stiffness (LS) usually decreases. However, information related to the impact of HIV co-infection in patients with advanced fibrosis is scarce. The aim was to analyze the impact of HIV co-infection on the LS dynamics after HCV cure. Methods Prospective study conducted in the GEHEP-011 multicenter cohort (initiated in October 2011-November 2023, ID NCT04460157), including patients with chronic HCV infection, with or without HIV co-infection, fulfilling: 1) SVR with direct-acting antivirals; 2) pre-treatment LS >= 9.5 kPa; 3) available measurement of LS at SVR. Pre-treatment, SVR and annual post-treatment LS were assessed. The primary outcome was time to LS normalization achievement (<= 7.2 kPa) in two consecutive examinations. Findings 1138 patients were included, 678 (60%) of whom were living with HIV (PLWH). The median time between the first to the last measure was 35 (17-69) months. In total, 390 [34% (95% confidence interval, 31%-37%)] patients achieved LS normalization, 169 [37% (CI 95%, 34%-43%)] individuals with HCV mono-infection vs. 221 [32% (CI 95%, 29%-36%)] PLWH achieved LS normalization (p = 0.003). The propensity score (PS) for HIV infection was calculated. In a multivariate model for competing risks (death was the competing event) adjusted for HIV, PS and diabetes, HIV infection was associated with a lower probability of achieving normalization [sHR = 0.82 (95% CI, 0.67-1.00), p = 0.045]. Matching by closer PS was performed. In the resultant subset, the probability of achieving LS normalization was again lower in PLWH [sHR = 0.76 (0.56-0.97), p < 0.001]. Interpretation After SVR, the probability of reaching LS normalization is significantly lower in PLWH. This could have implications on the development of long-term clinical events. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://incliva.portalinvestigacion.com/publicaciones/20652 |
| url |
https://incliva.portalinvestigacion.com/publicaciones/20652 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
ELSEVIER |
| publisher.none.fl_str_mv |
ELSEVIER |
| dc.source.none.fl_str_mv |
EClinicalMedicine ISSN: 25895370 reponame:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname:INCLIVA |
| instname_str |
INCLIVA |
| reponame_str |
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA |
| collection |
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869418342277709824 |
| score |
15,811543 |